Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis.

scientific article

Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis. is …
instance of (P31):
meta-analysisQ815382
systematic reviewQ1504425
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1043796683
P356DOI10.1186/CC13760
P8608Fatcat IDrelease_sn2ajunhhrdibenidx56sgdqpu
P932PMC publication ID4056761
P698PubMed publication ID24612487
P5875ResearchGate publication ID260681626

P50authorNaomi HammondQ29839624
Roman PfisterQ88713396
Matthias KochanekQ91845528
Guido MichelsQ118397045
Mariana Benevides MachadoQ118397101
Paul R IngramQ118397129
Timo LeygeberQ118397161
Elise CuquemelleQ118397186
Enrique PiacentiniQ118397200
Christian Brun-BuissonQ41907137
P2860cites workPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementQ21562278
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009Q28260987
Critically Ill patients with 2009 influenza A(H1N1) in MexicoQ28261205
Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling studyQ28269717
Emergence of a novel swine-origin influenza A (H1N1) virus in humansQ29616833
Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.Q51898034
The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures.Q54019322
Procalcitonin Guidance of Antibiotic Therapy in Community-acquired PneumoniaQ55966607
Antibiotic administration in community-acquired pneumoniaQ80332617
Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumoniaQ81109888
Critical care services and 2009 H1N1 influenza in Australia and New Zealand.Q30381497
Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.Q30383431
Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection.Q30384331
Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adultsQ30398779
Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre studyQ30400361
The utility of procalcitonin in diagnosis of H1N1 influenza in intensive care patients.Q30401757
Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adultsQ30408548
Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United StatesQ30415511
The behavior and diagnostic utility of procalcitonin and five other inflammatory molecules in critically ill patients with respiratory distress and suspected 2009 influenza a H1N1 infectionQ30415731
Immunopathogenesis of 2009 pandemic influenzaQ30423093
Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysisQ33980630
Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and futureQ34026963
Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithmsQ34028037
Can procalcitonin tests aid in identifying bacterial infections associated with influenza pneumonia? A systematic review and meta-analysis.Q34294231
Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysisQ34325775
Nonvalue of sputum culture in the management of lower respiratory tract infectionsQ37140266
Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitoninQ37318175
Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in SpainQ37443062
Procalcitonin for guidance of antibiotic therapyQ37747406
Role of procalcitonin in managing adult patients with respiratory tract infectionsQ37999770
Diagnostic utility of plasma procalcitonin for nosocomial pneumonia in the intensive care unit settingQ39967561
Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropeniaQ40512637
Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot studyQ45373299
Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unitQ47748488
P275copyright licenseCreative Commons Attribution 2.0 GenericQ19125117
P6216copyright statuscopyrightedQ50423863
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectprotein precursorQ258658
influenza A virus subtype H1N1Q161393
pandemicQ12184
influenza pandemicQ2723958
bacterial pneumoniaQ3776920
influenzaQ2840
calcitoninQ24783750
critical illnessQ65807521
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)R44
P577publication date2014-03-10
P1433published inCritical CareQ5186602
P1476titleProcalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis.
P478volume18